War in Ukraine and dialysis treatment: human suffering and organizational challenges.
Ukraine
dialysis
organizational challenges
patients
war
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
26
10
2022
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
In January 2021, there were 9648 patients in Ukraine on kidney replacement therapy, including 8717 on extracorporeal therapies and 931 on peritoneal dialysis. On 24 February 2022, foreign troops entered the territory of Ukraine. Before the war, the Fresenius Medical Care dialysis network in Ukraine operated three medical centres. These medical centres provided haemodialysis therapy to 349 end-stage kidney disease patients. In addition, Fresenius Medical Care Ukraine delivered medical supplies to almost all regions of Ukraine. Even though Fresenius Medical Care's share of end-stage kidney disease patients on dialysis is small, a brief narrative account of the managerial challenges that Fresenius Medical Care Ukraine and the clinical directors of the Fresenius Medical Care centres had to face, as well as the suffering of the dialysis population, is a useful testimony of the burden imposed by war on these frail, high-risk patients dependent on a complex technology such as dialysis. The war in Ukraine is causing immense suffering for the dialysis population of this country and has called for heroic efforts from dialysis personnel. The experience of a small dialysis network treating a minority of dialysis patients in Ukraine is described. Guaranteeing dialysis treatment has been and remains an enormous challenge in Ukraine and we are confident that the generosity and the courage of Ukrainian dialysis staff and international aid will help to mitigate this tragic suffering.
Identifiants
pubmed: 37007698
doi: 10.1093/ckj/sfad003
pii: sfad003
pmc: PMC10061431
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
676-683Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
Déclaration de conflit d'intérêts
All authors are Fresenius Medical Care employees. The results presented in this paper have not been published previously in whole or part.
Références
Methods Inf Med. 2004;43(1):83-8
pubmed: 15026844
Kidney Int Suppl (2011). 2016 Dec;6(2):35-41
pubmed: 30675418
Cancer Discov. 2022 May 2;12(5):1178
pubmed: 35344034
Clin Kidney J. 2018 Dec;11(6):803-809
pubmed: 30524715
Clin Nephrol. 2016 May;85(5):281-8
pubmed: 27007869
Nephrol Dial Transplant. 2010 Feb;25(2):538-44
pubmed: 19793930
J Nephrol. 2022 Apr;35(3):717-718
pubmed: 35301700
Kidney Int. 2009 Jun;75(11):1202-1208
pubmed: 19212421
Nat Rev Nephrol. 2022 Aug;18(8):479-480
pubmed: 35637382
Physiol Meas. 2006 Sep;27(9):921-33
pubmed: 16868355
Nephrol Dial Transplant. 2011 Aug;26(8):2595-603
pubmed: 21248293
J Nephrol. 2022 Mar;35(2):377-380
pubmed: 35246798
Nephrol Dial Transplant. 2022 Feb 25;37(3):469-476
pubmed: 33881541
Semin Nephrol. 2020 Jul;40(4):354-362
pubmed: 32800286
CJEM. 2022 Aug;24(5):471-472
pubmed: 35666371
Sex Reprod Healthc. 2022 Jun;32:100735
pubmed: 35605367
Am J Kidney Dis. 2021 Dec;78(6):804-815
pubmed: 34364906
Nephrol Dial Transplant. 2009 Oct;24(10):3251-5
pubmed: 19592598
Nephrol Dial Transplant. 2023 Jan 23;38(1):56-65
pubmed: 35998320